CNC vs RLAY · P/E 8.4, rev $103.52B vs rev $3.4M
Centene Corp (CNC) versus Relay Therapeutics Inc (RLAY) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Relay Therapeutics Inc (RLAY) is a biotechnology company listed on NASDAQ.
Latest reported CNC revenue for 2026-06-30 was $103.52B. Net income was $2.63B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported RLAY revenue for 2026-06-30 was $3.4M. Net income was -$157.0M. Revenue was up 11.7% from 2026-03-31 to 2026-06-30. RLAY currently screens at market cap $3.39B.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. RLAY currently screens at market cap $3.39B.
Not investment advice. Open the CNC and RLAY stock pages for the full models.
Not investment advice.